Healthcare Services

One of the Major Drivers of the m-RNA Synthesis Service Market Is the Rising Adoption Of Personalized Medicine Fueling The Growth Of The Market Due To Advancements In Genomic Sequencing And Demand For Tailored Therapies

April 2, 2026April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The m-RNA Synthesis Service Market Across 2026–2030?

The m-rna synthesis service market has demonstrated robust expansion in recent years. It is projected to increase from $4.99 billion in 2025 to $5.48 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.9%. This historical growth can be attributed to several factors, including the acceleration of vaccine research programs, increased funding allocated to genetic research, the expansion of contract research services, the growing application of mrna in academic studies, and advancements in transcription efficiency technologies.

The m-rna synthesis service market size is poised for robust expansion in the upcoming years. It is projected to achieve a valuation of $7.9 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.6%. This anticipated growth during the forecast period is primarily driven by factors such as the expanding development pipeline for mRNA-based therapeutics, the increasing need for personalized medicine approaches, the broadening scope of gene therapy research, a rising dependence on outsourced synthesis services, and a growing number of regulatory approvals for mRNA products. Prominent trends expected within this period include a heightened demand for customized mRNA constructs, the increasing adoption of GMP-grade mRNA production methods, a wider utilization of scalable in vitro transcription platforms, the expansion of rapid turnaround synthesis services, and an intensified emphasis on delivering high-purity mRNA outputs.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24611&type=smp

Which Market Drivers Are Supporting The Expansion Of The m-RNA Synthesis Service Market?

The increasing emphasis on personalized medicine is anticipated to fuel the expansion of the mRNA synthesis service market moving forward. Personalized medicine defines a medical strategy that customizes treatment and healthcare decisions based on an individual’s genetic makeup, lifestyle, and environment. The growth in personalized medicine stems from advancements in genomic sequencing, which enable more precise identification of specific genetic variations linked to disease and treatment response. mRNA synthesis services contribute to this focus on personalized medicine by facilitating the rapid and exact production of mRNA-based therapies tailored to an individual’s genetic profile, leading to more effective and targeted treatments. For instance, in February 2024, as per the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, representing a notable increase from 6 in 2022. Among these approvals, seven were cancer drugs, and three were developed for other diseases and conditions. Therefore, the heightened focus on personalized medicine is a key driver for the growth of the mRNA synthesis service market.

What Segmentation Levels Are Considered In The m-RNA Synthesis Service Market?

The m-rna synthesis service market covered in this report is segmented –

1) By Type: mRNA Vaccine Synthesis, mRNA Drug Synthesis

2) By Application Area: Vaccine Development, Therapeutic Development, Research and Development, Diagnostics

3) By End-user Industry: Pharmaceutical Companies, Biotechnology Firms, Academic And Research Institutions, Contract Research Organizations (CROs)

Subsegments:

1) By mRNA Vaccine Synthesis: Infectious Disease Vaccines, Cancer Vaccines, Personalized Vaccines

2) By mRNA Drug Synthesis: Protein Replacement Therapies, Gene Editing Therapeutics, Cell Therapy Support

Which Trends Are Shaping The Future Of The m-RNA Synthesis Service Market?

Major companies operating in the mRNA synthesis service market are channeling efforts into developing cutting-edge solutions, such as RNA polymerase innovations, aimed at enhancing the efficiency, yield, and safety of mRNA synthesis. RNA polymerase innovations pertain to the development of advanced enzymes capable of improving the transcription process, minimizing undesirable outcomes such as double-stranded RNA formation, and elevating the overall quality of mRNA for use in vaccines and therapeutics. For instance, in March 2025, Primrose Bio Inc., a US-based biotechnology company, introduced Prima RNApols to improve the efficiency and scalability of mRNA synthesis. This enzyme is characterized by enhanced processivity and high-fidelity transcription, which enables it to produce longer and more stable mRNA strands with reduced error rates. Its robust performance within in vitro transcription systems effectively minimizes impurities and boosts the overall yield, thus providing a reliable and scalable solution for companies involved in mRNA-based drug development. This innovation is especially valuable in the expanding field of personalized medicine, where precise and efficient mRNA synthesis is crucial.

Which Leading Firms Are Contributing To The Growth Of The m-RNA Synthesis Service Market?

Major companies operating in the m-rna synthesis service market are Thermo Fisher Scientific Inc., Danaher Corporation, AGC Biologics Inc., Eurofins Scientific SE, Lonza Group AG, Catalent Inc., Samsung Biologics Co. Ltd., WuXi Biologics (Cayman) Inc., GenScript Biotech Corporation, Azenta Inc., Genewiz Inc., New England Biolabs Inc., TransGen Biotech Co. Ltd., Creative Biolabs Inc., Bioneer Corporation, Aldevron LLC, eTheRNA immunotherapies NV, Bio-Synthesis Inc., TriLink BioTechnologies LLC, APExBIO Technology LLC

Read the full m-rna synthesis service market report here:

https://www.thebusinessresearchcompany.com/report/m-rna-synthesis-service-global-market-report

How Is The m-RNA Synthesis Service Market Distributed Across Key Geographic Regions?

North America was the largest region in the m-RNA synthesis service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the m-rna synthesis service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored m-RNA Synthesis Service Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24611&type=smp

Browse Through More Reports Similar to the Global m-RNA Synthesis Service Market 2026, By The Business Research Company

Contrast Media Global Market Report

https://www.thebusinessresearchcompany.com/report/contrast-media-global-market-report

Medical Imaging Global Market Report

https://www.thebusinessresearchcompany.com/report/medical-imaging-global-market-report

Portable Magnetic Resonance Imaging Mri Global Market Report

https://www.thebusinessresearchcompany.com/report/portable-magnetic-resonance-imaging-mri-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795